Bach P

Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim. Heidelberg University, Heidelberg, Germany.

1 paper

ArticlePsilocybin

Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder.

Köhne S, Hillemacher T, Glahn A +1

Europe PMC2024